Table of Contents Author Guidelines Submit a Manuscript
Malaria Research and Treatment
Volume 2013, Article ID 234683, 10 pages
http://dx.doi.org/10.1155/2013/234683
Clinical Study

Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes

1Laboratory for Public Health Research Biotechnologies, University of Yaounde, BP 8094, Yaounde, Centre Region, Cameroon
2Department of Biochemistry, University of Dschang, BP 67, Dschang, West Region, Cameroon
3Universite des Montagnes, BP 208, Bangante, West Region, Cameroon
4Faculty of Science, University of Buea, BP 63, Buea, South West Region, Cameroon

Received 30 June 2013; Revised 15 October 2013; Accepted 29 October 2013

Academic Editor: Polrat Wilairatana

Copyright © 2013 Innocent M. Ali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Innocent M. Ali, Palmer M. Netongo, Barbara Atogho-Tiedeu, et al., “Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes,” Malaria Research and Treatment, vol. 2013, Article ID 234683, 10 pages, 2013. https://doi.org/10.1155/2013/234683.